Barclays’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-31,037
| Closed | -$67K | – | 4451 |
|
|
2023
Q3 | $67K | Sell |
31,037
-374,782
| -92% | -$809K | ﹤0.01% | 3468 |
|
|
2023
Q2 | $735K | Buy |
405,819
+388,241
| +2,209% | +$703K | ﹤0.01% | 2363 |
|
|
2023
Q1 | $23K | Buy |
17,578
+8,359
| +91% | +$10.9K | ﹤0.01% | 3971 |
|
|
2022
Q4 | $15K | Buy |
9,219
+7,204
| +358% | +$11.7K | ﹤0.01% | 4086 |
|
|
2022
Q3 | $4K | Sell |
2,015
-39,538
| -95% | -$78.5K | ﹤0.01% | 4428 |
|
|
2022
Q2 | $127K | Sell |
41,553
-1,247
| -3% | -$3.81K | ﹤0.01% | 3369 |
|
|
2022
Q1 | $309K | Buy |
+42,800
| New | +$309K | ﹤0.01% | 3084 |
|